Muutke küpsiste eelistusi

WHO Reporting System for Lung Cytopathology [Pehme köide]

  • Formaat: Paperback / softback, 210 pages, kõrgus x laius x paksus: 270x208x12 mm, kaal: 1996 g, col. ill.
  • Sari: WHO Reporting Systems for Cytopathology 1
  • Ilmumisaeg: 14-Mar-2023
  • Kirjastus: IARC
  • ISBN-10: 9283245164
  • ISBN-13: 9789283245162
Teised raamatud teemal:
  • Formaat: Paperback / softback, 210 pages, kõrgus x laius x paksus: 270x208x12 mm, kaal: 1996 g, col. ill.
  • Sari: WHO Reporting Systems for Cytopathology 1
  • Ilmumisaeg: 14-Mar-2023
  • Kirjastus: IARC
  • ISBN-10: 9283245164
  • ISBN-13: 9789283245162
Teised raamatud teemal:
WHO Reporting System for Lung Cytopathology is Volume 1 of this new series of reporting systems for cytopathology, which is a joint project of the International Academy of Cytology (IAC) and the International Agency for Research on Cancer (IARC), a specialized agency of the World Health Organization (WHO). The series includes a unique synthesis of the published evidence and the practice of cytopathology, and it is linked to the WHO Classification of Tumours series, now in its 5th edition.

Cytopathologists look at tumours slightly differently than other specialists do, and there is a need for specialized reporting systems based on the key diagnostic cytopathological features of tumours, presented in standardized reports, within a hierarchical system of diagnostic categories. These categories must also be linked to diagnostic management recommendations to improve communication with clinicians and support patient care. And it is essential that these reporting systems be truly international, to serve the needs of patients worldwide in many differently medically resourced settings.

These volumes are an essential tool for standardizing diagnostic cytopathology practice worldwide and will serve as a vehicle for the translation of cytopathology research into practice. The key diagnostic cytopathological features are listed for each tumour type under a defined set of diagnostic categories and described in precise, uniform language. Thesediagnostic criteria represent the first international consensus and are underpinned by evidence that has been evaluated and debated by experts in the field. Each lesion-specific section includes a dedicated subsection discussing the differential diagnosis of the cytopathological features that can be used throughout the world, including in low-resource settings, followed by a subsection describing the current best-practice application of ancillary testing (including next-generation sequencing) on cytopathology material.

This volume:
  • Prepared by about 60 authors and editors
  • Contributors from around the world, reflecting an international expertise
  • More than 300 high-quality images
  • More than 1000 references
List of abbreviations
viii
Foreword ix
1 Introduction to the WHO Reporting System for Lung Cytopathology
1(12)
Background
2(4)
The role of lung cytopathology
6(2)
Diagnostic categories and report structure
8(3)
Risk of malignancy and management recommendations
11(2)
2 Lung cytopathology techniques
13(26)
Sampling methods FNAB techniques and specimen management
14(2)
Bronchial wash and bronchial brush techniques and specimen management
16(2)
Bronchoalveolar lavage techniques and specimen management
18(2)
Sputum sampling techniques and specimen management
20(2)
Rapid onsite evaluation
22(2)
Cell preparation methods
24(2)
Ancillary testing Introduction: The role of ancillary testing
26(1)
Immunocytochemistry
27(4)
In situ hybridization
31(3)
Molecular testing
34(5)
3 Diagnostic category: Insufficient/lnadequate/Non-diagnostic
39(8)
Introduction
40(1)
Definition
40(1)
Discussion and background
41(3)
Risk of malignancy and management recommendations
44(1)
Sample reports
45(2)
4 Diagnostic category: Benign
47(38)
Introduction
48(1)
Definition
48(1)
Discussion and background
49(1)
Risk of malignancy and management recommendations
50(1)
Inflammatory processes Acute inflammation and suppuration
51(2)
Histiocytic, lymphocytic, and eosinophilic inflammatory patterns
53(5)
Granulomatous disorders
58(3)
Inflammatory and reactive changes in glandular cells and squamous cells
61(5)
Benign neoplastic lesions Pulmonary hamartoma
66(2)
Sclerosing pneumocytoma
68(3)
Solitary tracheobronchial papilloma
71(1)
Salivary gland neoplasms
72(1)
PEComa
73(2)
Spindle cell tumours
75(3)
Meningiomas
78(1)
Granular cell tumour
79(2)
Ectopic thyroid and parathyroid tissues
81(2)
Sample reports
83(2)
5 Diagnostic category: Atypical
85(10)
Introduction
86(1)
Definition
86(1)
Discussion and background
87(3)
Risk of malignancy and management recommendations
90(1)
Sample reports
91(4)
6 Diagnostic category: Suspicious for malignancy
95(8)
Introduction
96(1)
Definition
96(1)
Discussion and background
97(2)
Risk of malignancy and management recommendations
99(1)
Sample reports
100(3)
7 Diagnostic category: Malignant
103(74)
Introduction
104(1)
Definition
104(1)
Discussion and background
105(3)
Risk of malignancy and management recommendations
108(1)
Specific malignant lesions Non-small cell carcinomas Adenocarcinoma of the lung
109(5)
Squamous cell carcinoma
114(4)
Non-small cell carcinoma NOS
118(2)
Other specific carcinomas Salivary gland-type carcinomas
120(3)
Adenosquamous carcinoma
123(3)
Pleomorphic carcinoma
126(2)
Pulmonary blastoma
128(1)
Carcinosarcoma
129(2)
NUT carcinoma
131(2)
Thoracic SMARCA4-deficient undifferentiated tumour
133(2)
Neuroendocrine neoplasms Neuroendocrine tumours Carcinoid/neuroendocrine tumours of the lung
135(4)
Neuroendocrine carcinomas Small cell lung carcinoma
139(3)
Large cell neuroendocrine carcinoma
142(2)
Lymphoproliferative diseases Lymphomas
144(3)
Pulmonary Langerhans cell histiocytosis
147(1)
Erdheim-Chester disease
148(2)
Other malignancies Spindle cell tumours
150(4)
Paraganglioma
154(2)
Diffuse pleural mesothelioma
156(7)
Primary germ cell tumours of the mediastinum
163(5)
Primary angiosarcoma of the lung
168(2)
Pulmonary and thoracic metastases
170(3)
Sample reports
173(4)
8 Management recommendations for each diagnostic category
177(12)
Introduction
178(1)
Insufficient/lnadequate/Non-diagnostic
179(2)
Benign
181(1)
Atypical
182(1)
Suspicious for malignancy
183(1)
Malignant
184(1)
Contributors
185(2)
Declaration of interests
187(2)
Sources 189(4)
References 193(16)
Subject Index 209